Metformin paired with cimetidine may raise risk of lactic acidosis in patients with renal failure: Study Medha Baranwal11 Jan 2024 7:00 PM ISTChina: Metformin combined with cimetidine may raise the risk of lactic acidosis (LA) in patients with mild-to-moderate renal failure (RF), a recent...
Higher AMH levels lower ovulation chances during induction with clomiphene and metformin in PCOS patients Medha Baranwal5 Jan 2024 10:15 PM ISTUSA: A recent study published in Fertility and Sterility has shown reduced odds of ovulation with ovulation induction (OI) with clomiphene, metformin,...
Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin MD Brand Connect2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Lupin Launches Dapaturn GM Range for Improved Approach to Manage Type 2 Diabetes MD Brand Connect1 Jan 2024 11:45 AM ISTGlobal pharma major Lupin Limited announced the launch of Dapaturn GM Forte for the treatment of diabetic patients in India. Lupin's Dapaturn GMâ„¢...
Modify eGFR value as per standard guidelines: CDSCO Panel Tells Hetero Lab on Antidiabetic FDC Drug Dr. Divya Colin31 Dec 2023 5:15 PM ISTNew Delhi: Reviewing the drug major Hetero Lab's revised Phase III clinical trial protocol of fixed-dose combination antidiabetic drug Sitagliptin...
Metformin and SGLT2 inhibitor combo may increase survival in diabetes patients with cirrhosis Medha Baranwal29 Dec 2023 2:00 AM ISTUSA: Dual treatment with metformin and SGLT2 inhibitor reduced hepatic complications and improved survival in type 2 diabetes (T2D) patients with...
Synokem Pharmaceutical Gets CDSCO Panel Nod To study Antidiabetic FDC Drug Dr. Divya Colin21 Dec 2023 6:00 PM ISTNew Delhi: With the condition of including more government sites distributed geographically, Synokem Pharmaceutical has got approval from the Subject...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Initiation of noninsulin second-line Antidiabetics fraught with risk of discontinuation within one year: Study Dr. Kamal Kant Kohli18 Dec 2023 12:30 AM ISTUSA: Adherence to second-line diabetes drugs can be hit or miss among patients with type 2 diabetes, a recent study has reported.The findings...
Modify phase III clinical trial protocol: CDSCO panel tells Akum Pharma on antidiabetic FDCÂ Dr. Divya Colin17 Dec 2023 5:30 PM ISTNew Delhi: Approving to conduct the bioequivalence (BE) study of the antidiabetic drug combination Repaglinide plus Voglibose plus Metformin...
Add on Metformin to insulin in pregnant women with diabetes fails to reduce neonatal complications: JAMA Medha Baranwal15 Dec 2023 10:15 AM ISTUSA: Metformin plus insulin treatment for preexisting type 2 or gestational diabetes diagnosed early in pregnancy failed to reduce a composite...
Conduct Phase III CT: CDSCO Panel Tells Akum Pharmaceutical on Antidiabetic FDC Dr. Divya Colin10 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the proposal for the clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
